亚太地区病毒样颗粒市场预测至 2028 年 - 按产品类型（肝炎、癌症/HPV 和戈谢病）、来源（酵母、昆虫细胞、植物等）和应用（疫苗）划分的 COVID-19 影响和区域分析和治疗）

亚太地区病毒样颗粒市场预计将从 2021 年的1,018.83 亿美元增长至1,769.02 美元到 2028 年将达到 100 万；预计 2021 年至 2028 年复合年增长率为 8.2%。

医疗保健市场的各个参与者和研究组织都积极参与产品创新和开发。使用病毒样颗粒是生物制药行业中使用的一种新兴方法。由于病毒样颗粒缺乏病毒成分，因此它们比实际的病毒成分更容易处理。 VLP 可用于辅助药物输送、成像、免疫治疗和治疗诊断。例如，根据 NCBI 2020 年 6 月发表的一项研究，VLP 可以纳米颗粒的形式用于光热疗法、PET 和 CT 成像、MRI 造影剂载体、光学成像、炎症和自身免疫性疾病疫苗等应用，癌症免疫疗法和小分子药物输送（在癌症治疗中）。因此，VLP 的此类潜在应用预计将在预测期内为市场参与者提供增长机会。

根据国际货币基金组织 (IMF) 报告预计 2020 年亚太地区的增长将继续停滞在 0%。这是近 60 年来最糟糕的增长表现，涉及全球金融危机 (4.7%) 和亚洲金融危机 (1.3%)。韩国的下调幅度较大，幅度为 3.5%，但由于澳大利亚、新西兰和泰国将长期停产时间降至 9%，因此似乎可以应对冠状病毒的缓慢传播。由于全球旅游业关闭，以及澳大利亚大宗商品价格下跌，这些国家受到了沉重打击。目前正在开发 COVID-19 疫苗的亚太地区包括韩国、中国、日本、泰国和越南。其中，中国有15种疫苗，印度和韩国有3种疫苗，日本有2种疫苗，泰国和越南有1种疫苗。其中疫苗包括10种灭活疫苗、6种蛋白亚单位疫苗、7种病毒载体疫苗、6种核酸疫苗。此外，推广安全、公平、有效的疫苗是亚太地区的首要任务。根据亚洲开发银行的报告，2020年12月，亚洲开发银行（ADB）与亚太疫苗获取机制（APVAX）启动了一项90亿美元的疫苗计划，将为发展中成员提供快速和公平的支持国家（发展中成员体）采购和提供有效且安全的 COVID-19 疫苗。通过疫苗接种，可以打破病毒传播链，挽救生命，减轻疫情的负面影响。

随着新冠病毒的出现，功能和技术，供应商可以吸引新客户并扩大其在新兴市场的足迹。这一因素可能会推动亚太地区病毒样颗粒市场的发展。预计亚太地区病毒样颗粒市场在预测期内将以良好的复合年增长率增长。

亚太地区类病毒颗粒市场收入及预测至 2028 年（百万美元）

亚太地区病毒样颗粒市场细分

亚太地区病毒样颗粒市场 –按产品类型

肝炎
癌症/HPV
戈谢病

亚太地区病毒样颗粒市场 -按来源

酵母
昆虫细胞
植物
其他

亚太类病毒颗粒市场 -按应用

疫苗
治疗

亚太地区病毒样颗粒市场 -按国家

亚太地区病毒样颗粒市场 –提及的公司

1. Introduction

1.1 Scope of the Study

1.2 The Insight Partners Research Report Guidance

1.3 Market Segmentation

1.3.1 Asia Pacific Virus-like Particles Market – By Product Type

1.3.2 Asia Pacific Virus-like Particles Market – By Source

1.3.3 Asia Pacific Virus-like Particles Market – By Application

1.3.4 Asia Pacific Virus-like Particles Market – By Country

2. Asia Pacific Virus-like Particles Market – Key Takeaways

3. Research Methodology

3.1 Coverage

3.2 Secondary Research

3.3 Primary Research

4. Asia Pacific Virus-like Particles Market Landscape

4.1 Overview

4.2 PEST Analysis

4.3 Experts Opinion

5. Asia Pacific Virus-like Particles Market – Key Market Dynamics

5.1 Market Drivers

5.1.1 Surging Prevalence of Infectious Viral Diseases

5.1.2 Increasing Role of Virus-Like Particles in Therapeutic Developments and Studies

5.2 Market Restraints

5.2.1 Reach of Alternative Technologies for Viral Vaccine Production

5.3 Market Opportunities

5.3.1 Growing Potential Applications in Therapeutics and Diagnostics

5.4 Future Trends

5.4.1 Steady Demand for Innovative and Effective Products

5.5 Impact Analysis

6. Asia Pacific Virus-like Particles Market Analysis

6.1 Asia Pacific Virus-like Particles Market Revenue Forecast and Analysis

7. Asia Pacific Virus-like Particles Market Analysis – by Product Type

7.1 Overview

7.2 Asia Pacific Virus-like Particles Market, by Product Type, 2021 & 2028 (%)

7.3 Hepatitis

7.3.1 Overview

7.3.2 Hepatitis: Virus-like Particles Market Revenue and Forecast to 2028 (US$ Million)

7.4 Cancer/ Human Papillomavirus (HPV)

7.4.1 Overview

7.4.2 Cancer/HPV: Virus-like Particles Market Revenue and Forecast to 2028 (US$ Million)

7.5 Gaucher Disease

7.5.1 Overview

7.5.2 Gaucher Disease: Virus-like Particles Market Revenue and Forecast to 2028 (US$ Million)

8. Asia Pacific Virus-like Particles Market Analysis – By Source

8.1 Overview

8.2 Asia Pacific Virus-like Particles Market Share, by Source, 2021 & 2028 (%)

8.3 Yeast

8.3.1 Overview

8.3.2 Yeast: Virus-like Particles Market Revenue and Forecast to 2028 (US$ Million)

8.4 Plant

8.4.1 Overview

8.4.2 Plant: Virus-like Particles Market Revenue and Forecast to 2028 (US$ Million)

8.5 Insect Cell

8.5.1 Overview

8.5.2 Insect Cell: Virus-like Particles Market Revenue and Forecast to 2028 (US$ Million)

8.6 Others

8.6.1 Overview

8.6.2 Others: Virus-like Particles Market Revenue and Forecast to 2028 (US$ Million)

9. Asia Pacific Virus-like Particles Market Analysis – By Application

9.1 Overview

9.2 Asia Pacific Virus-like Particles Market Share, by Application, 2021 & 2028 (%)

9.3 Vaccines

9.3.1 Overview

9.3.2 Vaccine: Virus-like Particles Market Revenue and Forecast to 2028 (US$ Million)

9.4 Therapeutics

9.4.1 Overview

9.4.2 Therapeutics: Virus-like Particles Market Revenue and Forecast to 2028 (US$ Million)

10. Asia Pacific Virus-like Particles Market – Country Analysis

10.1 Overview

10.1.1 Asia Pacific: Virus-like Particles Market Revenue and Forecast to 2028, by Country (%)

10.1.1.1 Japan: Virus-Like Particles Market Revenue and Forecast to 2028 (US$ Million)

10.1.1.1.1 Overview

10.1.1.1.2 Japan: Virus-Like Particles Market Revenue and Forecast to 2028 (US$ Million)

10.1.1.1.3 Japan: Virus-Like Particles Market Revenue and Forecasts to 2028, by Product Type (US$ Million)

10.1.1.1.4 Japan: Virus-Like Particles Market Revenue and Forecasts to 2028, by Source (US$ Million)

10.1.1.1.5 Japan Virus-like Particles Market, by Application - Revenue and Forecast to 2028 (US$ Million)

10.1.1.2 China: Virus-Like Particles Market Revenue and Forecast to 2028 (US$ Million)

10.1.1.2.1 Overview

10.1.1.2.2 China: Virus-Like Particles Market Revenue and Forecast to 2028 (US$ Million)

10.1.1.2.3 China Virus-like Particles Market, by Application - Revenue and Forecast to 2028 (US$ Million)

10.1.1.2.4 China: Virus-Like Particles Market Revenue and Forecasts to 2028, by Source (US$ Million)

10.1.1.2.5 China Virus-like Particles Market, by Application - Revenue and Forecast to 2028 (US$ Million)

10.1.1.3 India Virus-Like Particles Market Revenue and Forecast to 2028 (US$ Million)

10.1.1.3.1 Overview

10.1.1.3.2 India: Virus-like Particles Market Revenue and Forecast to 2028 (US$ Million)

10.1.1.3.3 India Virus-like Particles Market, by Application - Revenue and Forecast to 2028 (US$ Million)

10.1.1.3.4 India Virus-like Particles Market, by Source - Revenue and Forecast to 2028 (US$ Million)

10.1.1.3.5 India Virus-like Particles Market, by Application - Revenue and Forecast to 2028 (US$ Million)

10.1.1.4 South Korea: Virus-like Particles Market Revenue and Forecast to 2028 (US$ Million)

10.1.1.4.1 Overview

10.1.1.4.2 South Korea: Virus-like Particles Market Revenue and Forecast to 2028 (US$ Million)

10.1.1.4.3 South Korea Virus-like Particles Market, by Application - Revenue and Forecast to 2028 (US$ Million)

10.1.1.4.4 South Korea Virus-like Particles Market, by Source - Revenue and Forecast to 2028 (US$ Million)

10.1.1.4.5 South Korea Virus-like Particles Market, by Application - Revenue and Forecast to 2028 (US$ Million)

10.1.1.5 Australia: Virus-like Particles Market Revenue and Forecast to 2028 (US$ Million)

10.1.1.5.1 Overview

10.1.1.5.2 Australia: Virus-like Particles Market Revenue and Forecast to 2028 (US$ Million)

10.1.1.5.3 Australia Virus-like Particles Market, by Application - Revenue and Forecast to 2028 (US$ Million)

10.1.1.5.4 Australia Virus-like Particles Market, by Source - Revenue and Forecast to 2028 (US$ Million)

10.1.1.5.5 Australia Virus-like Particles Market, by Application - Revenue and Forecast to 2028 (US$ Million)

10.1.1.6 Rest of Asia Pacific: Virus-Like Particles Market – Revenue and Forecast to 2028 (US$ Million)

10.1.1.6.1 Overview

10.1.1.6.2 Rest of Asia Pacific: Virus-Like Particles Market – Revenue and Forecast to 2028 (US$ Million)

10.1.1.6.3 Rest of Asia Pacific Virus-like Particles Market, by Application - Revenue and Forecast to 2028 (US$ Million)

10.1.1.6.4 Rest of Asia Pacific Virus-like Particles Market, by Source - Revenue and Forecast to 2028 (US$ Million)

10.1.1.6.5 Rest of Asia Pacific Virus-like Particles Market, by Application - Revenue and Forecast to 2028 (US$ Million)

11. Impact Of COVID-19 Pandemic on Asia Pacific Virus-like Particles Market

11.1 Impact Assessment of COVID-19 Pandemic

12. Asia Pacific Virus-like Particles Market–Industry Landscape

12.1 Overview

12.2 Organic Developments

12.2.1 Overview

12.3 Inorganic Developments

12.3.1 Overview

13. Company Profiles

13.1 Merck & Co., Inc.

13.1.1 Key Facts

13.1.2 Business Description

13.1.3 Products and Services

13.1.4 Financial Overview

13.1.5 SWOT Analysis

13.1.6 Key Developments

13.2 GlaxoSmithKline plc.

13.2.1 Key Facts

13.2.2 Business Description

13.2.3 Products and Services

13.2.4 Financial Overview

13.2.5 SWOT Analysis

13.2.6 Key Developments

13.3 Pfizer Inc.

13.3.1 Key Facts

13.3.2 Business Description

13.3.3 Products and Services

13.3.4 Financial Overview

13.3.5 SWOT Analysis

13.3.6 Key Developments

13.4 Sanofi

13.4.1 Key Facts

13.4.2 Business Description

13.4.3 Products and Services

13.4.4 Financial Overview

13.4.5 SWOT Analysis

13.4.6 Key Developments

13.5 Wantai BioPharm

13.5.1 Key Facts

13.5.2 Business Description

13.5.3 Products and Services

13.5.4 Financial Overview

13.5.5 SWOT Analysis

13.5.6 Key Developments

13.6 Serum Institute of India Pvt. Ltd.

13.6.1 Key Facts

13.6.2 Business Description

13.6.3 Products and Services

13.6.4 Financial Overview

13.6.5 SWOT Analysis

13.6.6 Key Developments

13.7 BHARAT BIOTECH

13.7.1 Key Facts

13.7.2 Business Description

13.7.3 Products and Services

13.7.4 Financial Overview

13.7.5 SWOT Analysis

13.7.6 Key Developments

13.8 LG Chem

13.8.1 Key Facts

13.8.2 Business Description

13.8.3 Products and Services

13.8.4 Financial Overview

13.8.5 SWOT Analysis

13.8.6 Key Developments

14. Appendix

14.1 About The Insight Partners

14.2 Glossary of Terms

LIST OF TABLES

Table 1. Asia Pacific Virus-like Particles Market, Revenue and Forecast to 2028 (US$ Million)

Table 2. Japan: Virus-Like Particles Market Revenue and Forecasts to 2028, by Product Type (US$ Million)

Table 3. Japan: Virus-Like Particles Market Revenue and Forecasts to 2028, by Source (US$ Million)

Table 4. Japan Virus-like Particles Market, by Application - Revenue and Forecast to 2028 (US$ Million)

Table 5. China Virus-like Particles Market, by Application - Revenue and Forecast to 2028 (US$ Million)

Table 6. China: Virus-Like Particles Market Revenue and Forecasts to 2028, by Source (US$ Million)

Table 7. China Virus-like Particles Market, by Application - Revenue and Forecast to 2028 (US$ Million)

Table 8. India Virus-like Particles Market, by Application - Revenue and Forecast to 2028 (US$ Million)

Table 9. India Virus-like Particles Market, by Source - Revenue and Forecast to 2028 (US$ Million)

Table 10. India Virus-like Particles Market, by Application - Revenue and Forecast to 2028 (US$ Million)

Table 11. South Korea Virus-like Particles Market, by Application - Revenue and Forecast to 2028 (US$ Million)

Table 12. South Korea Virus-like Particles Market, by Source - Revenue and Forecast to 2028 (US$ Million)

Table 13. South Korea Virus-like Particles Market, by Application - Revenue and Forecast to 2028 (US$ Million)

Table 14. Australia Virus-like Particles Market, by Application - Revenue and Forecast to 2028 (US$ Million)

Table 15. Australia Virus-like Particles Market, by Source - Revenue and Forecast to 2028 (US$ Million)

Table 16. Australia Virus-like Particles Market, by Application - Revenue and Forecast to 2028 (US$ Million)

Table 17. Rest of Asia Pacific Virus-like Particles Market, by Application - Revenue and Forecast to 2028 (US$ Million)

Table 18. Rest of Asia Pacific Virus-like Particles Market, by Source - Revenue and Forecast to 2028 (US$ Million)

Table 19. Rest of Asia Pacific Virus-like Particles Market, by Application - Revenue and Forecast to 2028 (US$ Million)

Table 20. Organic Developments Done by Companies

Table 21. Inorganic Developments Done by Companies

Table 22. Glossary of Terms: Virus-like Particles Market

LIST OF FIGURES

Figure 1. Asia Pacific Virus-like particles Market Segmentation

Figure 2. Asia Pacific Virus-like particles Market Segmentation, By Country

Figure 3. Asia Pacific Virus-like Particles Market Overview

Figure 4. Hepatitis Held the Largest Share of the Product Type Segment in Asia Pacific Virus-like particles Market

Figure 5. India to Show Significant Growth during Forecast Period

Figure 6. Asia Pacific Virus-like Particles Market, Industry Landscape

Figure 7. Asia Pacific PEST Analysis

Figure 8. Asia Pacific Virus-like Particles Market: Impact Analysis of Drivers and Restraints

Figure 9. Asia Pacific Virus-like Particles Market– Revenue Forecast and Analysis to 2028

Figure 10. Asia Pacific Virus-like Particles Market, by Product Type, 2021 & 2028 (%)

Figure 11. Hepatitis: Virus-like Particles Market Revenue and Forecast to 2028 (US$ Million)

Figure 12. Cancer/HPV: Virus-like Particles Market Revenue and Forecast to 2028 (US$ Million)

Figure 13. Gaucher Disease: Virus-like Particles Market Revenue and Forecast to 2028 (US$ Million)

Figure 14. Asia Pacific Virus-like Particles Market Share, by Source, 2021 & 2028 (%)

Figure 15. Yeast: Virus-like Particles Market Revenue and Forecasts to 2028 (US$ Million)

Figure 16. Plant: Virus-like Particles Market Revenue and Forecasts to 2028 (US$ Million)

Figure 17. Insect Cell: Virus-like Particles Market Revenue and Forecasts to 2028 (US$ Million)

Figure 18. Others: Virus-like Particles Market Revenue and Forecasts to 2028 (US$ Million)

Figure 19. Asia Pacific Virus-like Particles Market Share, by Application, 2021 & 2028 (%)

Figure 20. Vaccine: Virus-like Particles Market Revenue and Forecasts to 2028 (US$ Million)

Figure 21. Therapeutics: Virus-like Particles Market Revenue and Forecasts to 2028 (US$ Million)

Figure 22. Asia Pacific Virus-like Particles Market Overview, by Country (2021)

Figure 23. Asia Pacific: Virus-like Particles Market Revenue and Forecast to 2028, by Country (%)

Figure 24. Japan: Virus-Like Particles Market Revenue and Forecast to 2028 (US$ Million)

Figure 25. China: Virus-like Particles Market Revenue and Forecast to 2028 (US$ Million)

Figure 26. India: Virus-like Particles Market Revenue and Forecast to 2028 (US$ Million)

Figure 27. South Korea: Virus-like Particles Market Revenue and Forecast to 2028 (US$ Million)

Figure 28. Australia: Virus-like Particles Market Revenue and Forecast to 2028 (US$ Million)

Figure 29. Rest of Asia Pacific: Virus-Like Particles Market – Revenue and Forecast to 2028 (US$ Million)

Figure 30. Impact of COVID-19 Pandemic in Asia Pacific Country Markets

Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the Asia Pacific virus-like particles market.
Highlights key business priorities in order to assist companies to realign their business strategies
The key findings and recommendations highlight crucial progressive industry trends in the Asia Pacific virus-like particles market, thereby allowing players across the value chain to develop effective long-term strategies
Develop/modify business expansion plans by using substantial growth offering developed and emerging markets
Scrutinize in-depth Asia Pacific market trends and outlook coupled with the factors driving the virus-like particles market, as well as those hindering it
Enhance the decision-making process by understanding the strategies that underpin commercial interest with respect to client products, segmentation, pricing, and distribution

Report Code
Full Name
Country Name
Email Id
Phone Number
Job Title
Company
Requirement
Note : Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Related Reports

Report Name	Published Date
Asia Pacific Wind Turbine Condition Monitoring Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Component (Hardware, and Software an..	May 2022
Asia Pacific Automotive System Simulation Software Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Type (Transmission, Engine, Elec..	May 2022
Asia Pacific Ground Engaging Tools Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Application (Excavators, Loaders, Bulldozers, an..	May 2022

Purchase Options

Single User License

$3000

$1800

Site License

$4000

$2400

Enterprise License

$5000